UK markets close in 7 hours 38 minutes

MorphoSys AG (MOR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.01+0.01 (+0.20%)
At close: 03:59PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in EUR. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
249,512
179,612
327,698
71,755
Cost of revenue
42,695
32,195
9,174
12,085
Gross profit
206,917
147,417
318,524
59,670
Operating expenses
Research development
290,811
225,211
141,427
108,432
Selling general and administrative
117,120
154,220
159,146
59,336
Total operating expenses
453,541
425,041
300,573
167,768
Operating income or loss
-246,624
-277,624
17,952
-108,098
Interest expense
388,824
65,824
96,214
2,272
Total other income/expenses net
-249,814
-245,114
8,708
1,050
Income before tax
-899,950
-591,050
22,492
-106,520
Income tax expense
-38,491
-76,591
-75,399
-3,506
Income from continuing operations
-861,460
-514,460
97,891
-103,014
Net income
-861,460
-514,460
97,891
-103,014
Net income available to common shareholders
-861,460
-514,460
97,891
-103,014
Basic EPS
-
-3.85
0.75
-0.81
Diluted EPS
-
-3.85
0.74
-0.81
Basic average shares
-
133,636
130,103
126,445
Diluted average shares
-
133,636
132,671
126,445
EBITDA
-
-515,135
127,036
-98,003